Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05178641 · ClinicalTrials.gov registry record · NA
Overnight Pant Study for Children With Nocturnal Enuresis
A NA study of Nocturnal Enuresis, sponsored by Procter and Gamble.
- Completed
- Registry status
- NA
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT05178641: Completed NA study of Nocturnal Enuresis, sponsored by Procter and Gamble.
NCT05178641 is a NA study of Nocturnal Enuresis that has completed, run by Procter and Gamble. The registered enrollment target is 32 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05178641, a NA study of Nocturnal Enuresis, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- NA
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the in-use tolerance of an absorbent disposable underwear pant developed for children with nocturnal enuresis by assessing adverse events. In addition product performance will be assessed by the parent at home via a daily diary.
Primary Outcome
Adverse Device Effect and Adverse Event tracking twice daily via a safety in-use diary.
Conditions Studied
Interventions
- DEVICE Ninjamas Pyjama Pants
- OTHER Participant's Overnight Current Standard of Care
Study Locations (1)
Ohio
- North Cliff Consultants - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2022-01-13 |
| Est. Completion | 2022-02-28 |
| Phase | NA |
What the finished NCT05178641 record still lists
NCT05178641 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 32 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Nocturnal Enuresis appearing as the primary indexed condition, and to 2 interventions - of which Ninjamas Pyjama Pants is the first listed.
NCT05178641 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT05178641 about?
NCT05178641 is a clinical study titled "Overnight Pant Study for Children With Nocturnal Enuresis". This study will evaluate the in-use tolerance of an absorbent disposable underwear pant developed for children with nocturnal enuresis by assessing adverse events. In addition product performance will be assessed by the parent at home via a daily diary.
What is the current status of trial NCT05178641?
This trial is currently completed. It is a NA study. The enrollment target is 32 participants. The study started on 2022-01-13. Estimated completion is 2022-02-28.
What conditions does trial NCT05178641 study?
This clinical trial studies the following conditions: Nocturnal Enuresis.
What interventions are being tested in trial NCT05178641?
The interventions under investigation include: Ninjamas Pyjama Pants (DEVICE), Participant's Overnight Current Standard of Care (OTHER).
Who is sponsoring clinical trial NCT05178641?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05178641 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nocturnal Enuresis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05178641's enrollment target sits among peer trials
32 1578th of 2000 higher than 409 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02445781 · 32 participants · Early Phase 1
Differing Levels of Hypoglycemia
- NCT02792270 · 32 participants · NA
Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT
- NCT03068910 · 32 participants · Early Phase 1
Hyperandrogenemia and Altered Day-night LH Pulse Patterns
- NCT03208868 · 32 participants · NA
Leucine Enriched Essential Amino Acid Mixture to Reverse Muscle Loss in Cirrhosis
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI